1. Baumgart DC, Sandborn WJ. Inflammatory bowel disease: clinical aspects and established and evolving therapies. The Lancet. 2007;369(9573):1641-57. [
DOI:10.1016/S0140-6736(07)60751-X]
2. Yoo JY, Groer M, Dutra SVO, Sarkar A, McSkimming DI. Gut microbiota and immune system interactions. Microorganisms. 2020;8(10):1587. [
DOI:10.3390/microorganisms8101587] [
PMID] [
PMCID]
3. Aponte M, Murru N, Shoukat M. Therapeutic, prophylactic, and functional use of probiotics: a current perspective. Front Microbiol. 2020;11:2120. [
DOI:10.3389/fmicb.2020.562048] [
PMID] [
PMCID]
4. Ailioaie LM, Litscher G. Probiotics, photobiomodulation, and disease management: Controversies and challenges. Int J Molec Sci. 2021;22(9):4942. [
DOI:10.3390/ijms22094942] [
PMID] [
PMCID]
5. Llewellyn A, Foey A. Probiotic modulation of innate cell pathogen sensing and signaling events. Nutrients. 2017;9(10):1156. [
DOI:10.3390/nu9101156] [
PMID] [
PMCID]
6. Abdulkhaleq L, Assi M, Abdullah R, Zamri-Saad M, Taufiq-Yap Y, Hezmee M. The crucial roles of inflammatory mediators in inflammation: A review. Veterinary World. 2018;11(5):627. [
DOI:10.14202/vetworld.2018.627-635] [
PMID] [
PMCID]
7. Wang Z, Li S, Cao Y, et al. Oxidative stress and carbonyl lesions in ulcerative colitis and associated colorectal cancer. Oxid Med Cell Long. 2016;2016. [
DOI:10.1155/2016/9875298] [
PMID] [
PMCID]
8. Kalla R, Ventham N, Kennedy N, et al. MicroRNAs: new players in IBD. Gut. 2015;64(3):504-13. [
DOI:10.1136/gutjnl-2014-307891] [
PMID] [
PMCID]
9. Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, et al. Intestinal anti-inflammatory effect of the probiotic Saccharomyces boulardii in DSS-induced colitis in mice: Impact on microRNAs expression and gut microbiota composition. J Nutr Biochem. 2018;61:129-39. [
DOI:10.1016/j.jnutbio.2018.08.005] [
PMID]
10. Valmiki S, Ahuja V, Paul J. MicroRNA exhibit altered expression in the inflamed colonic mucosa of ulcerative colitis patients. World J Gastroenterol. 2017;23(29):5324. [
DOI:10.3748/wjg.v23.i29.5324] [
PMID] [
PMCID]
11. Luo X, Ranade K, Talker R, Jallal B, Shen N, Yao Y. MicroRNA-mediated regulation of innate immune response in rheumatic diseases. Arthritis Res Ther. 2013;15(2):1-13. [
DOI:10.1186/ar4194] [
PMID] [
PMCID]
12. Rodríguez-Nogales A, Algieri F, Garrido-Mesa J, et al. The administration of Escherichia coli Nissle 1917 ameliorates development of DSS-induced colitis in mice. Front Pharmacol. 2018;9:468. [
DOI:10.3389/fphar.2018.00468] [
PMID] [
PMCID]
13. Frăţilă O, Iliaş TI. COX-2 and Ki-67 immunohistochemical markers in the assessment of long-standing ulcerative colitis associated dysplasia. Rom J Morphol Embryol. 2013;54(1):143-9.
14. Mahmoudian A, Markham PF, Noormohammadi AH, Browning GF. Kinetics of transcription of infectious laryngotracheitis virus genes. Compar Immunol, Microbiol Infect Dis. 2012;35(2):103-15. [
DOI:10.1016/j.cimid.2011.11.001] [
PMID]
15. Abtahi Froushani SM, Mashouri S. The beneficial effects of hypiran in ameliorating rat model of ulcerative colitis. Zahedan J Res Med Sci. 2018;20(1). [
DOI:10.5812/zjrms.58919]
16. Sun Y, Li L, Xie R, Wang B, Jiang K, Cao H. Stress triggers flare of inflammatory bowel disease in children and adults. Front Pediatr. 2019;7:432. [
DOI:10.3389/fped.2019.00432] [
PMID] [
PMCID]
17. Hu T, Wang H, Xiang C, Mu J, Zhao X. Preventive effect of Lactobacillus acidophilus XY27 on DSS-induced ulcerative colitis in mice. Drug Design Develop Ther. 2020;14:5645. [
DOI:10.2147/DDDT.S284422] [
PMID] [
PMCID]
18. Peter ME. Targeting of mRNAs by multiple miRNAs: the next step. Oncogene. 2010;29(15):2161-4. [
DOI:10.1038/onc.2010.59] [
PMID]
19. Jung H, Kim JS, Lee KH, et al. Roles of microRNAs in inflammatory bowel disease. Int J Biol Sci. 2021;17(8):2112-23. [
DOI:10.7150/ijbs.59904] [
PMID] [
PMCID]
20. Li M, Marin-Muller C, Bharadwaj U, Chow KH, Yao Q, Chen C. MicroRNAs: control and loss of control in human physiology and disease. World J Surg. 2009;33(4):667-84. [
DOI:10.1007/s00268-008-9836-x] [
PMID] [
PMCID]
21. Grondin JA, Kwon YH, Far PM, Haq S, Khan WI. Mucins in intestinal mucosal defense and inflammation: learning from clinical and experimental studies. Front Immunol. 2020;11:2054. [
DOI:10.3389/fimmu.2020.02054] [
PMID] [
PMCID]
22. Chen W, Zhuo M, Lu X, et al. SRC-3 protects intestine from DSS-induced colitis by inhibiting inflammation and promoting goblet cell differentiation through enhancement of KLF4 expression. Int J Biol Sci. 2018;14(14):2051. [
DOI:10.7150/ijbs.28576] [
PMID] [
PMCID]
23. Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler Thromb Vasc Biol. 2011;31(5):986-1000. [
DOI:10.1161/ATVBAHA.110.207449] [
PMID] [
PMCID]
24. Hou Y, Janczuk A, Wang P. Current trends in the development of nitric oxide donors. Curr Pharmaceut Des. 1999;5(6):417-42.
25. Krishn SR, Batra SK, Kaur S. Advances in miRNA-mediated mucin regulation. Curr Pharmacol Rep. 2015;1(6):355-64. [
DOI:10.1007/s40495-014-0010-x] [
PMID] [
PMCID]
26. Ahrne S, Johansson Hagslatt M-L. Effect of lactobacilli on paracellular permeability in the gut. Nutrients. 2011;3(1):104-17. [
DOI:10.3390/nu3010104] [
PMID] [
PMCID]
27. Cichon C, Sabharwal H, Rüter C, Schmidt MA. MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions. Tissue Barriers. 2014;2(4):e944446. [
DOI:10.4161/21688362.2014.944446] [
PMID] [
PMCID]
28. Wan J, Xia L, Xu W, Lu N. Expression and function of miR-155 in diseases of the gastrointestinal tract. Int J Molec Sci. 2016;17(5):709. [
DOI:10.3390/ijms17050709] [
PMID] [
PMCID]
29. Hübenthal M. Phenotype prediction based on microRNA expression profiles: a novel diagnostic tool for inflammatory bowel disease 2019. https://macau.uni-kiel.de/receive/diss_mods_00025631.
30. James JP, Riis LB, Malham M, Høgdall E, Langholz E, Nielsen BS. MicroRNA biomarkers in IBD-differential diagnosis and prediction of colitis associated cancer. Int J Molec Sci. 2020;21(21):7893. [
DOI:10.3390/ijms21217893] [
PMID] [
PMCID]
31. Mueller AC, Sun D, Dutta A. The miR-99 family regulates the DNA damage response through its target SNF2H. Oncogene. 2013;32(9):1164-72. [
DOI:10.1038/onc.2012.131] [
PMID] [
PMCID]
32. Okayama H, Schetter AJ, Harris CC. MicroRNAs and inflammation in the pathogenesis and progression of colon cancer. Digest Disease. 2012;30(Suppl. 2):9-15. [
DOI:10.1159/000341882] [
PMID] [
PMCID]
33. Coskun M, Bjerrum JT, Seidelin JB, Troelsen JT, Olsen J, Nielsen OH. miR-20b, miR-98, miR-125b-1*, and let-7e* as new potential diagnostic biomarkers in ulcerative colitis. World J Gastroenterol. 2013;19(27):4289. [
DOI:10.3748/wjg.v19.i27.4289] [
PMID] [
PMCID]
34. Han C, Yu Z, Duan Z, Kan Q. Role of microRNA-1 in human cancer and its therapeutic potentials. Biomed Res Int. 2014;2014. [
DOI:10.1155/2014/428371] [
PMID] [
PMCID]